| Primary |
| Biliary Cirrhosis Primary |
28.6% |
| Product Used For Unknown Indication |
28.6% |
| Blood Triglycerides Increased |
14.3% |
| Drug Use For Unknown Indication |
14.3% |
| Hepatitis C |
14.3% |
|
| Burning Sensation |
20.0% |
| Gastritis |
20.0% |
| Hepatic Enzyme Increased |
20.0% |
| Paranoia |
20.0% |
| Rash |
20.0% |
|
| Secondary |
| Acute Lymphocytic Leukaemia |
28.1% |
| Product Used For Unknown Indication |
22.8% |
| Antiviral Prophylaxis |
8.8% |
| Hypertension |
5.3% |
| Anaemia |
3.5% |
| Gastrooesophageal Reflux Prophylaxis |
3.5% |
| Nocturia |
3.5% |
| Prostatic Disorder |
3.5% |
| Antibiotic Prophylaxis |
1.8% |
| Antifungal Prophylaxis |
1.8% |
| Anxiety |
1.8% |
| Blood Triglycerides Increased |
1.8% |
| Diabetes Mellitus |
1.8% |
| Diarrhoea |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Insomnia |
1.8% |
| Liver Transplant Rejection |
1.8% |
| Lyme Disease |
1.8% |
| Maternal Drugs Affecting Foetus |
1.8% |
| Mineral Supplementation |
1.8% |
|
| International Normalised Ratio Increased |
16.7% |
| Trigger Finger |
16.7% |
| Cholelithiasis |
8.3% |
| Hepatic Steatosis |
8.3% |
| Leukocytoclastic Vasculitis |
8.3% |
| Ocular Icterus |
8.3% |
| Paranoia |
8.3% |
| Pruritus |
8.3% |
| Tachycardia Foetal |
8.3% |
| Viral Infection |
8.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.3% |
| Drug Use For Unknown Indication |
22.2% |
| Liver Transplant |
4.3% |
| Hormone Replacement Therapy |
4.2% |
| Pain |
4.1% |
| Prophylaxis Against Transplant Rejection |
3.2% |
| Prophylaxis |
3.0% |
| Nausea |
2.8% |
| Hypertension |
2.7% |
| Hepatitis C |
2.4% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Acute Myeloid Leukaemia |
1.9% |
| Depression |
1.9% |
| Nuclear Magnetic Resonance Imaging |
1.8% |
| Insomnia |
1.7% |
| Asthma |
1.6% |
| Vomiting |
1.6% |
| Anxiety |
1.4% |
| Osteoporosis |
1.4% |
| Constipation |
1.4% |
|
| Thrombocytopenia |
10.6% |
| Somnolence |
9.2% |
| Vomiting |
7.7% |
| Pyrexia |
7.0% |
| Sepsis |
6.3% |
| Thirst |
4.9% |
| Weight Decreased |
4.9% |
| Withdrawal Syndrome |
4.9% |
| Death |
4.2% |
| Pulmonary Embolism |
4.2% |
| Transplant Rejection |
4.2% |
| Urinary Tract Infection |
4.2% |
| Weight Increased |
4.2% |
| Liver Transplant Rejection |
3.5% |
| Renal Failure Chronic |
3.5% |
| Respiratory Failure |
3.5% |
| Stress |
3.5% |
| Wrong Technique In Drug Usage Process |
3.5% |
| Hepatic Enzyme Increased |
2.8% |
| Hepatitis C |
2.8% |
|
| Interacting |
| Blood Triglycerides Increased |
25.0% |
| Hormone Replacement Therapy |
25.0% |
| Nocturia |
25.0% |
| Prostatic Disorder |
25.0% |
|
| Paranoia |
50.0% |
| Trigger Finger |
50.0% |
|
